Neuro-Oncology Reviews
Volume
26 Number 21
30 September 2024
Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 21, 30 September
Landry AP, Yefet LS, Wang JZ, Zadeh G, Nassiri F.
Methylation
profiling in the contemporary management of meningioma.
J
Neurooncol. 2024 Sep 22. doi:
10.1007/s11060-024-04825-w. PMID:
39306649. Review˰ ˍ
Le Guillou Horn XM, Lecellier F, Giraud C, Naudin M, Fayolle P,
Thomarat C, Fernandez-Maloigne C, Guillevin R.
From
Voxel to Gene: A Scoping Review on MRI Radiogenomics' Artificial
Intelligence Predictions in Adult Gliomas and Glioblastomas-The
Promise of Virtual Biopsy?
Biomedicines.
2024 Sep 23;12(9):2156. doi:
10.3390/biomedicines12092156. PMID:
39335670. Review. ˍ
Liu M, Li T, Zhao M, Qian C, Wang R, Liu L, Xiao Y, Xiao H, Tang
X, Liu H.
Nanoradiosensitizers in
glioblastoma treatment: recent advances and future perspectives.
Nanomedicine
(Lond). 2024 Sep 23;19(26):2229-2249. doi:
10.1080/17435889.2024.2395238. PMID:
39311492. Review˰ ˍ
Awuah WA, Ben-Jaafar A, Karkhanis S, Nkrumah-Boateng PA, Kong JSH,
Mannan KM, Shet V, Imran S, Bone M, Boye ANA, Ranganathan S, Shah
MH, Abdul-Rahman T, Atallah O.
Cancer
stem cells in meningiomas: novel insights and therapeutic
implications.
Clin
Transl Oncol. 2024 Sep 24. doi:
10.1007/s12094-024-03728-6. PMID: 39316249. Review.
ˍ
Ganguly K, Adhikary K, Acharjee A, Acharjee P, Trigun SK, Mutlaq
AS, Ashique S, Yasmin S, Alshahrani AM, Ansari MY.
Biological
significance and pathophysiological role of Matrix
Metalloproteinases in the Central Nervous System.
Int
J Biol Macromol. 2024 Sep 24;280(Pt 3):135967. doi:
10.1016/j.ijbiomac.2024.135967. PMID:
39322129. Review˰ ˍ
Pathikonda S, Amirmahani F, Mathew D, Muthukrishnan SD.
Histone
acetyltransferases as promising therapeutic targets in
glioblastoma resistance.
Cancer
Lett. 2024 Sep 24;604:217269. doi:
10.1016/j.canlet.2024.217269. PMID:
39326554. Review. ˍ
Viswanathan A, Brahma N, S V.
Transforming
brain cancer therapeutics: unlocking the power of blood-brain
barrier-targeting strategies for superior treatment outcomes and
precision medicine.
Neurosurg
Rev. 2024 Sep 24;47(1):673. doi:
10.1007/s10143-024-02873-4. PMID:
39316196. Review. ˍ
Gonzales CN, Negussie MB, Krishna S, Ambati VS, Hervey-Jumper SL.
Malignant glioma remodeling of
neuronal circuits: therapeutic opportunities and repurposing of
antiepileptic drugs.
Trends
Cancer. 2024 Sep 25:S2405-8033(24)00192-4. doi:
10.1016/j.trecan.2024.09.003. PMID:
39327186. Review. ˍ
Varela ML, Comba A, Faisal SM, Argento A, Peña Aguelo JA,
Candolfi M, Castro MG, Lowenstein PR.
Cell
and gene therapy in neuro-oncology.
Handb
Clin Neurol. 2024 Sep 26;205:297-315. doi:
10.1016/B978-0-323-90120-8.00009-5. PMID:
39341660. Review. ˍ
Demaliaj D, Gardner SL.
Novel
therapies for pediatric low grade glioma.
Curr
Opin Neurol. 2024 Sep 27. doi:
10.1097/WCO.0000000000001319. PMID:
39324939. Review˰ ˍ
Hajikarimloo B, Hasanzade A, Sabbagh Alvani M, Habibi MA.
Application of bevacizumab in the
management of meningiomas: a systematic review and meta-analysis.
Neurosurg
Rev. 2024 Sep 27;47(1):692. doi:
10.1007/s10143-024-02889-w. PMID:
39327340. Review˰ ˍ
Jiacheng D, Jiayue C, Ying G, Shaohua W, Wenhui L, Xinyu H.
Research progress and challenges of
the PD-1/PD-L1 axis in gliomas.
Cell
Biosci. 2024 Sep 27;14(1):123. doi:
10.1186/s13578-024-01305-6. PMID:
39334448. Review. ˍ
Verly G, Bresciani L, Delfino T, Nascimento M, Magill ST, Galvão
GDF.
Surgery alone versus surgery plus
adjuvant radiotherapy for WHO grade 2 meningioma: meta-analysis of
reconstructed time-to-event data.
Neurosurg
Rev. 2024 Sep 28;47(1):702. doi:
10.1007/s10143-024-02946-4. PMID:
39333271. Meta-analysis˰
ˍ
Lizunou Y, Potthoff AL, Schäfer N, Waha A, Borger V,
Herrlinger U, Vatter H, Schuss P, Schneider M.
Cerebellar
glioblastoma in adults: a comparative single-center matched pair
analysis and systematic review of the literature.
J
Cancer Res Clin Oncol. 2024 Sep 28;150(9):432. doi:
10.1007/s00432-024-05959-0. PMID:
39340649. Observational study; Review. ˍ
Mercado NB, Real JN, Kaiserman J, Panagioti E, Cook CH, Lawler SE.
Clinical implications of
cytomegalovirus in glioblastoma progression and therapy.
NPJ
Precis Oncol. 2024 Sep 29;8(1):213. doi:
10.1038/s41698-024-00709-4. PMID:
39343770. Review. ˍ
Rudà R, Pellerino A, Soffietti R.
Blood
and cerebrospinal fluid biomarkers in
neuro-oncology.
Curr
Opin Neurol. 2024 Sep 30. doi:
10.1097/WCO.0000000000001317. PMID:
39329301. Review˰ ˍ
Chen H, Anastasiadis P, Woodworth GF.
MR
Imaging-Guided Focused Ultrasound-Clinical Applications in
Managing Malignant Gliomas.
Magn
Reson Imaging Clin N Am.
2024 Jun 22;32(4):673-679. doi:
10.1016/j.mric.2024.05.006. PMID:
39322356. Review˰ ˍ
Dharia AA, Miller C, Pearson CM.
The
Role of Neuropsychology in Neurosurgical
Care: A Review of the Literature.
Neurol
Clin. 2024 Jun 25;42(4):889-902. doi:
10.1016/j.ncl.2024.05.013. PMID:
39343482. Review˰ ˍ
Bhangale PN, Kashikar SV, Kasat PR, Shrivastava P, Kumari A.
A
Comprehensive Review on the Role of MRI in the Assessment of
Supratentorial Neoplasms: Comparative Insights Into Adult and
Pediatric Cases.
Cureus.
2024 Aug 23;16(8):e67553. doi:
10.7759/cureus.67553. PMID:
39310617. Review. ˍ
Pasqualetti F, Lombardi G, Gadducci G, Giannini N, Montemurro N,
Feletti A, Zeppieri M, Somma T, Caffo M, Bertolotti C, Ius T.
Brain Stem Glioma Recurrence:
Exploring the Therapeutic Frontiers.
J
Pers Med. 2024 Aug 25;14(9):899. doi:
10.3390/jpm14090899. PMID:
39338153. Review. ˍ
Riahi F, Kiani P, Golabbakhsh A, Khanezarrin M, Abbaspour M,
Dormiani Tabatabaei SA, Fesharaki S, Tooyserkani SH, Bakhshi R,
Azizollahi S, Mohammadi H.
Comparison
of PET/CT and PET/MRI in central nervous system tumors, a
narrative review.
Int
J Physiol Pathophysiol Pharmacol. 2024 Aug
25;16(4):89-95. doi:
10.62347/UMDS1961. PMID:
39310737. Review. ˍ
McBenedict B, Hauwanga WN, Pogodina A, Singh G, Thomas A, Ibrahim
AMA, Johnny C, Lima Pessôa B.
Approaches
in Adult Glioblastoma Treatment: A Systematic Review of Emerging
Therapies.
Cureus.
2024 Aug 26;16(8):e67856. doi:
10.7759/cureus.67856. PMID:
39328617. Review. ˍ
Valerio J, Borro M, Proietti E, Pisciotta L, Olarinde IO,
Fernandez Gomez M, Alvarez Pinzon AM.
Systematic
Review and Clinical Insights: The Role of the Ketogenic Diet in
Managing Glioblastoma in Cancer Neuroscience.
J
Pers Med. 2024 Aug 31;14(9):929. doi:
10.3390/jpm14090929. PMID:
39338183. Review. ˍ
Feng F, Shen J, Qi Q, Zhang Y, Ni S.
Empowering
brain tumor management: chimeric antigen receptor macrophage
therapy.
Theranostics.
2024 Sep 3;14(14):5725-5742. doi:
10.7150/thno.98290. PMID:
39310093. Review. ˍ
Wei Y, Xu Y, Sun Q, Hong Y, Liang S, Jiang H, Zhang X, Zhang S,
Chen Q.
Targeting ferroptosis opens new
avenues in gliomas.
Int
J Biol Sci. 2024 Sep 3;20(12):4674-4690. doi:
10.7150/ijbs.96476. PMID:
39309434. Review. ˍ
Tataranu LG, Turliuc S, Kamel A, Rizea RE, Dricu A, Staicu GA,
Baloi SC, Rodriguez SMB, Manole AIM.
Glioblastoma
Tumor Microenvironment: An Important Modulator for Tumoral
Progression and Therapy Resistance.
Curr
Issues Mol Biol. 2024 Sep 5;46(9):9881-9894. doi:
10.3390/cimb46090588. PMID:
39329940. Review. ˍ
Xu E, Patterson J, Angione A, Li A, Wu DW, Akca E, Elghawy O,
Barsouk A, Sussman JH.
Low-Grade
Glioma Clinical Trials in the United States: A Systematic Review.
Life
(Basel). 2024 Sep 9;14(9):1133. doi:
10.3390/life14091133. PMID:
39337916. Review. ˍ
Giuliani P, De Simone C, Febo G, Bellasame A, Tupone N, Di Virglio
V, di Giuseppe F, Ciccarelli R, Di Iorio P, Angelucci S.
Proteomics Studies on Extracellular
Vesicles Derived from Glioblastoma: Where Do We Stand?
Int
J Mol Sci. 2024 Sep 10;25(18):9778. doi:
10.3390/ijms25189778. PMID:
39337267. Review. ˍ
Leili FR, Shali N, Sheibani M, Jafarian MJ, Pashizeh F, Gerami R,
Iraj F, Lashkarshekan AA.
Detailed
pathological role of non-coding RNAs (ncRNAs) in regulating drug
resistance of glioblastoma, and update.
Pathol
Res Pract. 2024 Sep 12;263:155590. doi:
10.1016/j.prp.2024.155590. PMID:
39326365. Review˰ ˍ
Inocencio JF, Mitrasinovic S, Asad M, Parney IF, Zang X, Himes BT.
Immune checkpoint pathways in
glioblastoma: a diverse and evolving landscape.
Front
Immunol. 2024 Sep 13;15:1424396. doi:
10.3389/fimmu.2024.1424396. PMID:
39346924. Review. ˍ
Sipos D, Debreczeni-Máté Z, Ritter Z, Freihat O,
Simon M, Kovács Á.
Complex
Diagnostic Challenges in Glioblastoma: The Role of 18F-FDOPA
PET Imaging.
Pharmaceuticals
(Basel). 2024 Sep 15;17(9):1215. doi:
10.3390/ph17091215. PMID:
39338377. Review. ˍ
Ma Y, Huang Y, Hu F, Shu K.
Lipid
metabolic rewiring in glioma-associated
microglia/macrophages (Review).
Int
J Mol Med. 2024 Sep 16;54(5):102. doi:
10.3892/ijmm.2024.5426. PMID:
39301636. Review. ˍ
Cooksey LC, Friesen DC, Mangan ED, Mathew PA.
Prospective
Molecular Targets for Natural Killer Cell Immunotherapy against
Glioblastoma Multiforme.
Cells.
2024 Sep 17;13(18):1567. doi:
10.3390/cells13181567. PMID:
39329751. Review. ˍ
Robert JA, Leclerc A, Ducloie M, Emery E, Agostini D, Vigne J.
Contribution of [18F]FET
PET in the Management of Gliomas, from Diagnosis to Follow-Up: A
Review.
Pharmaceuticals
(Basel). 2024 Sep 18;17(9):1228. doi:
10.3390/ph17091228. PMID:
39338390. Review. ˍ
Cortes Ballen AI, Amosu M, Ravinder S, Chan J, Derin E, Slika H,
Tyler B.
Metabolic Reprogramming in
Glioblastoma Multiforme: A Review of Pathways and Therapeutic
Targets.
Cells.
2024 Sep 19;13(18):1574. doi:
10.3390/cells13181574. PMID:
39329757. Review. ˍ
Manescu Paltanea V, Antoniac I, Paltanea G, Nemoianu IV, Mohan AG,
Antoniac A, Rau JV, Laptoiu SA, Mihai P, Gavrila H, Al-Moushaly
AR, Bodog AD.
Magnetic Hyperthermia in
Glioblastoma Multiforme Treatment.
Int
J Mol Sci. 2024 Sep 19;25(18):10065. doi:
10.3390/ijms251810065. PMID:
39337552. Review. ˍ
Qin Z, Bian XW, Shi Y.
Identification
of hypoxic macrophages in glioblastoma: Unveiling therapeutic
insights from tumour microenvironment analysis.
Clin
Transl Med. 2024 Sep 19;14(9):e70013. doi:
10.1002/ctm2.70013. PMID:
39297872. Editorial. ˍ
Strika Z, Petković K, Likić R.
Effectiveness
and Safety of mRNA Vaccines in the Therapy of Glioblastoma.
J
Pers Med. 2024 Sep 19;14(9):993. doi:
10.3390/jpm14090993. PMID:
39338247. Perspective. ˍ
Bondarev AD, Jonsson J, Chubarev VN, Tarasov VV, Lagunas-Rangel
FA, Schiöth HB.
Recent
developments of topoisomerase inhibitors: Clinical trials,
emerging indications, novel molecules and global sales.
Pharmacol
Res. 2024 Sep 20:107431. doi:
10.1016/j.phrs.2024.107431. PMID:
39307213. Review. ˍ
Debreczeni-Máté Z, Freihat O, Törő I,
Simon M, Kovács Á, Sipos D.
Value
of 11C-Methionine PET Imaging in High-Grade Gliomas: A Narrative
Review.
Cancers
(Basel). 2024 Sep 20;16(18):3200. doi:
10.3390/cancers16183200. PMID:
39335171. Review. ˍ
Ijaz M, Ullah Z, Aslam B, Khurshid M, Chen P, Guo B.
From
promise to progress: the dynamic landscape of glioblastoma
immunotherapy.
Drug
Discov Today. 2024 Sep 20;29(11):104188. doi:
10.1016/j.drudis.2024.104188. PMID:
39307298. Review˰ ˍ